$25 million gift from Once Upon a Time Foundation establishes Raynor Cerebellum Project at UT Southwestern to tackle cerebellar dysfunction and disorders


A generous $25 million commitment from the Once Upon a Time Foundation will create the Raynor Cerebellum Project at UT Southwestern Medical Center (RCP-UTSW) to investigate diseases associated with cerebellum dysfunction, with the goal of discovering how to preserve and restore lost brain function.

Active phase calorie restriction enhances longevity, UT Southwestern neuroscience study reveals


A new study in mice led by neuroscientists at UT Southwestern’s Peter O’Donnell Jr. Brain Institute shows that it’s not just calories that count, but also when they’re consumed.

UTSW researchers identify key complex for ribosome generation


UT Southwestern researchers have identified a four-protein complex that appears to play a key role in generating ribosomes – organelles that serve as protein factories for cells – as well as a surprising part in neurodevelopmental disorders.

UTSW study finds cognitive decline key factor in predicting life expectancy in Alzheimer’s disease


Cognitive decline is the biggest factor in determining how long patients with Alzheimer’s disease will live after being diagnosed, according to a new study from researchers at UT Southwestern.

Single protein prompts mature brain cells to regenerate multiple cell types


A single protein can reverse the developmental clock on adult brain cells called astrocytes, morphing them into stem-like cells that produce neurons and other cell types, UT Southwestern researchers report in a PNAS study.

UT Southwestern campaign infuses $1B into
Peter O’Donnell Jr. Brain Institute


UT Southwestern Medical Center has completed a five-year, $1 billion campaign to fuel its commitment to advance brain research and clinical care at its Peter O’Donnell Jr. Brain Institute, making it one of the largest brain-focused investments at a U.S. academic medical center.

UTSW study finds it safe to give clot-busting drug to stroke patients who took blood thinners


Stroke patients on long-term blood thinners who were given the clot-busting drug alteplase enjoyed better recoveries than those who did not receive the drug and had no increased risk of bleeding, a new study led by UTSW researchers shows.

Hibbs honored with Hackerman Award for work on structure and function of receptors in the brain


UT Southwestern structural biologist and neuroscientist Ryan Hibbs, Ph.D., has received a 2022 Norman Hackerman Award in Chemical Research.

High-tech sleeping bag could solve vision issues in space


A subtle smile emerged on Dr. James Leidner’s face as he envisioned telling people of the unusual contribution he made to mankind’s mission to Mars.

Scientists find first in human evidence of how memories form


UT Southwestern researchers have identified the characteristics of more than 100 memory-sensitive neurons that play a central role in how memories are recalled in the brain.